NVO congressional trades
Novo Nordisk A/S Common Stock (NVO) appears in 24 congressional disclosure rows from 8 members of Congress in 2025–2026 periodic reports: 15 purchases and 9 sales, with trade dates from Oct 29, 2024 to Sep 10, 2026. C. Franklin reported the most, with 7 rows. The median gap between trade date and filing date is 22 days, and 3 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live NVO portfolio or a trading signal.
- 24
- 8
- 15 / 9
- $80K – $500K
- sum of reported ranges
- 2026-09-10
Verified NVO congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 15 purchases and 9 sales. Reported owners: Self, Spouse. Transaction dates run from 2024-10-29 to 2026-09-10.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Kevin Hern | Novo Nordisk A/S Common Stock | Sale | Self | $1,001 - $15,000 | #20035491 Filed 2026-09-25 | |
| Kevin Hern | Novo Nordisk A/S Common Stock | Sale | Self | $1,001 - $15,000 | #20035491 Filed 2026-09-25 | |
| C. Franklin | Novo Nordisk A/S Common Stock | Purchase | Self | $1,001 - $15,000 | #20035450 Filed 2026-09-17 | |
| Alan Armstrong | Novo Nordisk A/S Common Stock | Purchase | Self | $15,001 - $50,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Lisa McClain | Novo Nordisk A/S Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | Novo Nordisk A/S Common Stock | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | Novo Nordisk A/S Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Marjorie Greene | Novo Nordisk A/S Common Stock | Purchase | Self | $1,001 - $15,000 | #20033314 Filed 2025-10-20 | |
| Lisa McClain | Novo Nordisk A/S Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032129 Filed 2025-10-22 | |
| Marjorie Greene | Novo Nordisk A/S Common Stock | Purchase | Self | $1,001 - $15,000 | #20030996 Filed 2025-08-29 | |
| Marjorie Greene | Novo Nordisk A/S Common Stock | Purchase | Self | $15,001 - $50,000 | #20030944 Filed 2025-08-20 | |
| Lisa McClain | Novo Nordisk A/S Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030932 Filed 2025-09-12 | |
| C. Franklin | Novo Nordisk A/S Common Stock | Purchase | Self | $15,001 - $50,000 | #20030918 Filed 2025-08-14 | |
| C. Franklin | Novo Nordisk A/S Common Stock | Purchase | Self | $1,001 - $15,000 | #20030918 Filed 2025-08-14 | |
| C. Franklin | Novo Nordisk A/S Common Stock | Purchase | Self | $1,001 - $15,000 | #20030918 Filed 2025-08-14 | |
| C. Franklin | Novo Nordisk A/S Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030918 Filed 2025-08-14 | |
| Lisa McClain | Novo Nordisk A/S Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | Novo Nordisk A/S Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Laurel Lee | Novo Nordisk A/S Common Stock | Sale | Spouse | $1,001 - $15,000 | #20030458 Filed 2025-06-22 | |
| C. Franklin | Novo Nordisk A/S Common Stock | Purchase | Self | $1,001 - $15,000 | #20029132 Filed 2025-04-11 | |
| C. Franklin | Novo Nordisk A/S Common Stock | Purchase | Self | $15,001 - $50,000 | #20029132 Filed 2025-04-11 | |
| Byron Donalds | Novo Nordisk A/S Common Stock | Sale | Self | $1,001 - $15,000 | #20029092 Filed 2025-04-14 | |
| Byron Donalds | Novo Nordisk A/S Common Stock | Sale | Spouse | $1,001 - $15,000 | #20029092 Filed 2025-04-14 | |
| Valerie Hoyle | Novo Nordisk A/S Common Stock | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
NVO disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| C. Franklin's NVO trades | 7 | 7 | 0 | 2026-08-26 |
| Lisa McClain's NVO trades | 7 | 3 | 4 | 2025-10-31 |
| Marjorie Greene's NVO trades | 3 | 3 | 0 | 2025-10-15 |
| Byron Donalds | 2 | 0 | 2 | 2025-03-20 |
| Kevin Hern | 2 | 0 | 2 | 2026-09-10 |
| Alan Armstrong | 1 | 1 | 0 | 2026-03-30 |
| Laurel Lee | 1 | 0 | 1 | 2025-05-08 |
| Valerie Hoyle | 1 | 1 | 0 | 2024-10-29 |
How long disclosure took
Days from trade date to filing date for 24 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 10
- 16–30 days
- 7
- 31–45 days
- 4
- Over 45 days
- 3
- Median / longest
- 22d / 318d
Source documents
15 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #20035491Filed 2026-09-25 · 2 rows
- #20035450Filed 2026-09-17 · 1 row
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 1 row
- #20033446Filed 2025-11-21 · 3 rows
- #20032129Filed 2025-10-22 · 1 row
- #20033314Filed 2025-10-20 · 1 row
- #20030932Filed 2025-09-12 · 1 row
- #20032070Filed 2025-09-12 · 1 row
- #20030996Filed 2025-08-29 · 1 row
- #20030944Filed 2025-08-20 · 1 row
- #20030918Filed 2025-08-14 · 4 rows
- #20030891Filed 2025-08-13 · 2 rows
3 older filings are linked from the transaction table.
What NVO filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
NVO congressional trades: FAQ
Who in Congress traded NVO?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 24 verified NVO rows from 8 members: Alan Armstrong, Byron Donalds, C. Franklin, Kevin Hern, and 4 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current NVO holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are NVO amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is NVO congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (177 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded NVO.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-10-14. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported NVO and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included